Gsa Capital Partners LLP Cytokinetics Inc Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	BUY	$26.88 - $83.49 $111,955 - $347,735	4,165 New	4,165 $347,000
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $221,527 - $313,380	5,748 New	5,748 $278,000
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $1.34 Million - $1.81 Million	-38,942 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $721,984 - $1.39 Million	38,942 New	38,942 $1.39 Million
Q1 2020 May 12, 2020	SELL	$8.75 - $16.3 $630,577 - $1.17 Million	-72,066 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$7.95 - $11.84 $572,924 - $853,261	72,066 New	72,066 $765,000
Q4 2017 Feb 14, 2018	SELL	$7.25 - $15.65 $93,525 - $201,885	-12,900 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$12.0 - $15.0 $154,800 - $193,500	12,900	12,900 $187,000

407

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.